Scientist- Oligonucleotide Analytics

1100 Mylan Pharmaceuticals Inc.; Morgantown (WV); On-site; USD 90,000 - 130,000; Full time

Job summary

Viatris in Morgantown, WV seeks a Scientist- Oligonucleotide Analytics to develop and validate analytical methods for therapeutic oligonucleotide drug substances and drug products in our world-class R&D center.

The role requires a Ph.D. in Biochemistry, Analytical Chemistry or Chemistry with knowledge of therapeutic oligonucleotides (preferred), or a Master’s in Biochemistry with 5+ years of oligonucleotide research; strong lab skills, report writing, and excellent communication across functions.

Qualifications

• PhD in Biochemistry/Analytical Chemistry or Chemistry preferred.
• MS in Biochemistry with 5+ years oligonucleotide research may be considered.
• Strong laboratory skills and instrumentation for analytical characterization.

Responsibilities

• Develop and validate analytical methods using advanced instrumentation for therapeutic oligonucleotide substances and products.
• Apply sound scientific principles to perform laboratory research.

Skills

Analytical instrumentation

Laboratory techniques

Multi-tasking

Communication skills

Technical report writing

Education

PhD in Biochemistry/Analytical Chemistry/Chemistry

Master’s in Biochemistry with 5+ years oligonucleotide research

Tools

Analytical instrumentation

Job description

Mylan Pharmaceuticals Inc. Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. We have been included on number of award lists that demonstrate the impact we are making. Every day, we rise to the challenge to make a difference and here’s how the Scientist- Oligonucleotide Analytics role will make an impact:

Key responsibilities for this role include:

• Working in our world-class Research and Development Center, the incumbent will develop and validate analytical methods using advanced instrumentation for therapeutic oligonucleotide drug substances and drug products.
• Apply sound scientific principles to perform laboratory research.

The minimum qualifications for this role are:

• Fresh Ph.D in Biochemistry, Analytical Chemistry or Chemistry with knowledge of Therapeutic Oligonucleotides is preferred.
• A Master’s degree in Biochemistry with at least 5 years of experience preferably in Oligonucleotide research will also be considered.
• Must possess knowledge of basic laboratory techniques and instrumentation employed in the analytical characterization of complex pharmaceutical products.
• Must possess excellent communication (oral and written) and organizational skills.
• Must be able to multi-task and drive multiple projects and assigned responsibilities.
• Must possess the ability to write comprehensive technical reports and communicate complex concepts to colleagues across functions.
• Proficiency in speaking, comprehending, reading, and writing English is required.
• A general understanding of current regulatory policies applicable to pharmaceutical industry practice and regulations is preferable.

At Viatris, we offer competitive salaries, benefits and an inclusive environment where you can use your experiences, perspectives and skills to help make an impact on the lives of others.

Viatris is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, national origin, religion, age, color, sex, sexual orientation, gender identity, gender expression, disability, or protected veteran status, or any other characteristic protected by local, state, or federal laws, rules, or regulations.

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance. We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.